Genotypic and phenotypic variations in methicillin-resistant
Staphylococcus aureus isolates from outpatient, inpatient and nursing homes infections may be asymptomatic many months prior to the onset of symptoms, resulting in reported transmission of HA-MRSA for a significant proportion of CA-MRSA cases [13, 14] . Genetic analyses of MRSA isolates from around the world, however, have revealed that HA-MRSA and CA-MRSA are genetically distinct. The defining feature of MRSA is the staphylococcal cassette chromosome mec (SCCmec). MRSA has emerged in five types of SCCmec lineages; types I, II and III: (HA-MRSA), type IV: (CA-MRSA) and some (HA-MRSA), and type V: (CA-MRSA) [12, 15] . Most notably, SCCmec type II is seen in US HA-MRSA, while SCCmec IV is primarily associated with CA-MRSA [12, 15, 16] . The staphylococcal cassette typing serves as a useful tool in understanding the epidemiology of MRSA.
Soon after the initial description of SCCmec, several structurally different SCCmec elements were described. These elements included mecA and cassette chromosome recombinases (ccr) gene allotypes in mec and ccr gene complexes, respectively. These markers have been routinely used to classify SCCmec element subtypes [17] . Other genetic markers are also associated with MRSA. For instance, most CA-MRSA strains carry the Panton-Valentine Leukocidin (pvl) gene [16, 18] , leading to leukocyte destruction [19, 20] , skin abscesses and necrotizing pneumonitis [19, 21, 22] , suggesting a higher degree of virulence. The accessory gene regulator (agr) locus of S. aureus is recognized as a quorum-sensing gene cluster, coordinating gene expression in response to the density of bacterial population [23] . Although the differential regulation of agr gene expression may vary in different S. aureus strains [24] , genes involved in the resistance to methicillin (e.g. mecA) are upregulated by agr in the CA-MRSA strains but much less in the HA-MRSA strains [25] . Staphylococcal protein A (SpA) is the product of a single locus gene (spa). SpA is anchored in the bacterial cell wall envelope and is released during staphylococcal growth. This marker has been used as the molecular identification for discrimination of S. aureus in outbreak settings [26] .
The epidemiological shift in MRSA distribution from healthcare-related facilities to the general population is distressing and requires focused efforts from healthcare professionals to manage and control the rate of incidences. In the current report, we have studied the epidemiology of 521 human MRSA isolates from hospitals, nursing homes and outpatient clinics by categorizing the genotypic variations of isolates over 12 consecutive months. We utilized SCCmec, mec, agr, ccr, pvl and spa molecular markers to classify MRSA isolates into distinct genetic profiles in order to correlate the phenotypic variabilities and environmental preferences of each profile. We further compared the genetics profiles in respect to antibiotic resistance to 27 antibiotics, source of specimen, patient's location, age and sex. The findings provide a retrospective analysis of MRSA epidemiology based on genetic markers and presents further data to characterize the epidemiological nature of this pathogen.
RESuLTS

Comparison of genetic markers
SCCmec, mec, agr, ccr, pvl, spa genetic markers, for 521 MRSA isolates as well as eight MRSA and one MSSA references were determined. Fig. 1a -c shows representative PCR products for these studies. Larsen et al. (2008) were specific to the mecA gene, they used different sets of primers and therefore generated different fragments as indicated by their differences in size (147 bp (Fig. 1c) and 162 bp (Fig. 1b) , respectively). The most common spa fragment was spa413 (n=417, 78.7%) followed by spa380 (n=34, 6.4%) and spa315 (n=35, 6.6%). The agr profile was dominated by agr1 (n=308, 58.1%) and agr2 (n=205, 38.7%), while agr3 and agr4 were found in 9 (1.7 %) and 8 (1.5 %) isolates, respectively. Fig. 2a-f shows the distribution of genetic markers among the isolates.
Patient demographics
Of the 521 clinical isolates included in the study, 326 (62.5 %) isolates were from outpatients, 104 (19.9 %) were from nursing homes, and 91 (17.6 %) were from inpatient sources. The age of patients ranged from 1.5 months to 97 years old with an average age of 49.2 years (median 49). The total number of isolates was similarly distributed between females and males, 51.2 % (n=267) and 48.8 % (n=254), respectively. The most common specimen source was wound (n=374), followed by upper and lower respiratory track (n=87), urine (n=30), eye (n=7), blood (n=5) and miscellaneous (n=18). To determine the genetic diversity among the isolates, SCCmec typing was used to generate a dendogram based on Jaccard similarity coefficient. Fig. 3 shows the phylogenetic relationship among 97 distinct profiles based on SCCmec types and presents a wide genetic heterogeneity among the isolates.
Epidemiological variability
Based on the molecular profile, the samples were divided into 97 distinct profiles. Profiles with an insufficient number of isolates were not included in the subsequent statistical analysis. The most prevalent profiles were P17 (n=176) and P33 (n=131), which made up 59% of total isolates. Profile 17 harboured SCCmec IVa, ccr2, mecB, agr1, pvl and spa413 fragments, while profile 33 harboured SCCmec II, ccr2 +ccr3, mecA, agr2, spa413 fragment and no pvl ( Table 1) .
P33 was more prevalent in the older population (average age 70.7 years, median 75), while P17 was routinely seen in the young and middle-aged populations (average age 33.9 year, median 28). The rate of incidence for P33 was significantly higher for females than males (62 % vs. 38 %), while P17 showed no significant difference in male and female distribution. P33 had a larger proportion of isolates from inpatient (35%) and nursing homes (21%) locations, while P17 isolates were primarily from outpatient locations (77%). The primary specimen sources for P33 was wound (52%), urine (11.4%) and respiratory (29%), while the primary source of isolates for P17 was wounds (88%). Table 2 shows the distribution of patient sex, age, location and source for P17 and P33.
Antibiogram
The diagnosis of MRSA infection was determined based on clinical laboratory culture findings for resistance to oxacillin (OXA). All profiles show high sensitivity to aminoglycosides (GEN), tetracyclines (CHL, TET, VAN), rifamycin (RIF). P33 exhibited a high rate of antibiotic resistance to penicillins (PEN, AMC, AMP, SAM), cephalosporins (CRO, CTX), fluoroquinolones (CIP, LVX, OFX, GAT, MXF and NOR) and macrolides (AZM, ERY), while P17 isolates had a similar antibiogram except for lower resistance to fluoroquinolones (Fig.  4a) . Neither P33 nor P17 exhibited an age-dependent antibiotic resistance pattern within their respective profiles, but between profiles, P33 showed a consistently high resistance rate across all age groups, while P17 had a lower resistance rate in respect to patients' age ( Fig. 4b-c ).
dISCuSSIon
To identify the role of genetic profile on phenotypic and environmental variations, 521 MRSA isolates were categorized based on six genetic markers. Our goal was to establish a comparative analysis of various strains of MRSA from dissimilar environments to elucidate the interaction between genetic variability and environmental preferences. The isolates were from various sources (i.e. wound, respiratory, urine) and collected from outpatient, inpatient and nursing home locations over 12 months as described in the methodology.
Molecular and epidemiological studies have shown that HA-MRSA differ both phenotypically and genotypically from CA-MRSA [27] . CA-MRSA tend to be faster in growth, more virulent, resistant to fewer antibiotic classes, and lower in the degree of beta lactam resistance [28] . In addition, HA-MRSA strains are known to carry type I-III SCCmec, while CA-MRSA strains are shown to carry SCCmec type-IVa [28] . In the current study, mecA detection by Larsen's method [29] was seen in 97.9% of all isolates. However, the results of mecA amplification by Zhang et al.'s method [30] suggest the emergence of mecB, which is distantly related to mecAgene homologue, and encodes a putative beta-lactamase that confers methicillin resistance to the strain [31] . The presence of SCCmec IVa in P17 is consistent with CA-MRSA strains [32] that was routinely associated with wound specimens (88%) from outpatient locations (77%), while P33 isolates carry SCCmec II, which has been previously shown to be associated with HA-MRSA [16] and more common in hospitals (35%) and nursing homes (21%). P33 isolates did not carry pvl, which is also consistent with previous reports indicating pvl absence in HA-MRSA [16] , while P17 carried pvl, which is previously reported in CA-MRSA [18] . Thus, based on the molecular distribution as well as patient location, it is reasonable to consider P17 and P33 to be a relative representation of CA-MRSA and HA-MRSA in the population, respectively. However, it is important to note that inpatient (15%) and nursing homes (8%) isolates made up 23% of patients in P17, while 44% of isolate in P33 were from outpatient sources. This observation suggests a gradual blending of patient population in community and hospital acquired MRSA in which the routine transmission of HA-MRSA may be very likely accounted for a significant proportion of CA-MRSA cases and vice versa. Therefore, identification of isolates into CA-MRSA or HA-MRSA based on the patients' time of admission seems to be subject to significant misclassification. The phylogenetic relations based on SCCmec types supports the blending of community and hospital-acquired MRSA across all profiles. Remarkably, unlike any other profile, P33 was more common in females than males (62% vs 38%). Differences in MRSA preponderance between male and female has previously been reported [33] . The observed differences in P33 distribution may be due to the broad-spectrum activity and prophylactic use of antibiotics to treat urinary tract infection and cystitis that are most frequent clinical bacterial infections in women, accounting for nearly 25% of all infections per year in the Fig. 3 . To determine the genetics relatedness of the MRSA population, 97profiles were characterized in respect to SCCmec subtype. A dendrogram was constructed based on the Jaccard similarity coefficient of genetic markers. Similarity coefficient is a measure of similarity for the two or more sets of data, with a range from 0 to 1. The closer the index to 1, the more similar the populations. The dendogram indicates that many MRSA profiles are distantly related to one another, suggesting a wide genetic heterogeneity in sample population.
United States [34, 35] . Previous reports have demonstrated that bacteria have a capacity to acquire an increased mutation rate over time under selective environmental pressure [36, 37] . Such hypermutable strains can adapt to a succession of environmental bottle necks, and as a result, develop a large variability of alleles that can survive the stressful conditions. Thus, ineffective administration of antimicrobial agents, therapeutically or as prophylaxis, may introduce or select for mutations that may remain at a low resistance level within the normal flora, increasing the chance of higher resistance levels under the selective pressure of causative agents -such as frequent exposure to antibiotics -over time. Therefore, it is conceivable that improper antibiotic usage generates a favourable environment for acquisition of more resistant strains throughout patients' life span, which may explain the higher rate of fluoroquinolone resistance in the older female dominated P33.
Multiple studies have also shown high fluoroquinolone resistance among MRSA specimens [38] ; several reported relationship between fluoroquinolone resistance and patient age in various bacteria [39] [40] [41] [42] [43] . There was low fluoroquinolone resistance in P17 with an average age of 33.3 years, and higher resistance rate in P33 with an average age 70.7 years. We have previously reported on the relationship between patient age and resistance to fluoroquinolones, characterized by an increase rate of resistance as the patient age increases [43] . However, that report was based on the phenotypic categorization of isolates. In the current report, the isolates were categorized based on genetic makers, SCCmec, mec, agr, ccr, pvl and spa. This categorization indicates a higher rate of resistance to fluoroquinolones in P33 and a lower variable rate of resistance in P17. However, when data was analysed within each profile, there was no correlation between the rate of antibiotic resistance and patient age. P33 isolates were consistently resistant to fluoroquinolones across all age groups (age range 1-92 years), while P17 isolates demonstrated a low resistance rate with variable degrees with no age association (age range 1-88 years). Although P33 isolates were more common in the older population (median age 75), and P17 isolates were more common among the younger population (median age 28), there was no correlation between patients' age and increased resistance to fluoroquinolones within each respective profile. This finding suggests that although the rate of antibiotic resistance to fluoroquinolone is higher in the older population, this increase is a direct result of genetic variability of the isolates rather than the patients' age. Since the previous report was only based on the phenotypic variation, the age-dependent resistance rate in respect to fluoroquinolones was a product of combined observation and subject to type-I statistical error.
Fluoroquinolones are antibacterial agents that target DNA gyrase subunits of topoisomerase II and parC and/or parE subunits of topoisomerase IV on chromosomal DNA [44] [45] [46] [47] [48] . The existence of multiple fluoroquinolone targets suggests a multi-step mechanism for the acquisition of a resistant phenotype. Low levels of fluoroquinolone resistance may be a product of single mutation in either DNA gyrases or topoisomerases, and once reduced sensitivity to the drug arises from the first mutation, higher levels of resistance may be reached from additional mutations [49] [50] [51] . In such a cooperative mutation, which requires multiple mutations to gain a resistance phenotype, acquisition of a resistant phenotype would occur considerably less frequently than a single independent mutation, requiring a longer time for the development of a phenotypic resistance profile, which may explain the high fluoroquinolone resistance in the older P33. In addition, a higher rate of resistance to fluoroquinolone may also be due in part to the higher usage of fluoroquinolones in the older patients and association between fluoroquinolone usage with an increase in nosocomial MRSA infections [52, 53] . It is also important to note that ineffective antibiotic treatment against a specific strain of pathogen may, in the long-term, increase the emergence of resistant profiles for other species either by selecting for mutant strains and/or by horizontal gene transfer from unrelated resistant species. If this assumption holds true, for instance, ineffective antibiotic treatment of Escherichia coli for urinary tract infections, would raise the risk of subsequent emergence of other antibiotic resistant strains, such as MRSA, by selecting for resistant mutations over time. With that perspective, the emergence of multidrug-resistant strains in older female dominated P33 suggests fluoroquinolone alternatives should be given higher priority than fluoroquinolones in the routine treatment of younger patients because the routine application of fluoroquinolones in the younger population will undermine the efficacy of fluoroquinolones to treat more serious infections later in life. The requirements for multiple mutations and the fact that many bacteria such as S. aureus naturally colonize the human body may account for the increased rate of fluoroquinolone resistance in older female dominated P33.
In summary, the current report suggests that the evolutionary adaptation of micro-organisms' resistance to antibiotics should be considered a natural phenomenon resulting from the adaptation to the selective pressure of antibiotics. Genetic malleability facilitates such an adaptation by random mutation and the consequential outcome of each mutation in respect to the environment. Thus, it appears evident that no antibiotics can escape the emergence of resistance, stressing the need for the development of better preventive measures and infection control strategies. The diversity of SCCmec MRSA isolates and unique environmental preferences for each profile highlights the importance of epidemiological knowledge of MRSA distribution to determine the best treatment for patients in both community and hospital settings.
METHodoLogy
The genetic and phenotypic variability of methicillin-resistant Staphylococcus aureus (MRSA) isolates was retrospectively characterized in respect to the specimen source, patient location, sex and age. The MRSA genetic diversity was determined using three different multiplex PCRs for their variation in SCCmec complex, mec, agr, ccr, pvl and spa specificity.
MRSA collection and screening
This study was reviewed and approved by Kent State Univer- To better appreciate the local MRSA diversity, the isolates were characterized using three different PCR techniques.
Spa, pvl and mecA
The Spa, pvl and mecA profiles were analysed by multiplex -PCR developed by Larsen et al. in 2008 [29] . Each PCR contained 0.45 µM mecA primers (mecA P4, 5′-TCCA GATT ACAA CTTC ACCAGG; mecA P7, 5′-CCACTTCA TATCTT-GTAACG), 0.18 µM spa primers (spa-1113-F, 5′-TAAA GACG ATCC TTCG GTGAGC; spa-1514 R, 5′-CAGC AGTA GTGC CGTT TGCTT), 1 µM pvl primers (pvl-F, 5′-GCTG GACA AAAC TTCT TGGAATAT; pvl-R, 5′-ATAG GACA CCAA TAAA TTCT GGATTG). Amplification was performed with an initial denaturation at 94 °C for 15 min, followed by 30 cycles of 94 °C for 30 s, 59 °C for 1 min and 72 °C for 1 min, with a final 72 °C for 10 min. The PCR products were analysed based on the amplicon sizes based on the band migration and comparison with the molecular marker.
SCCmec complex
The SCCmec complex type was determined using the multiplex -PCR developed by Zhang et al. [30] . with their specific primers for SCCmec types and subtypes I, II, III, IVa, IVb, IVc, IVd and V, the mecA and mecI genes, and ccr types (1, 2, 3 and 5) [16, 28] . PCRs were performed as previously described (primer sequences will be provided upon request): beginning with an initial denaturation step at 94 °C for 5 min followed by 10 cycles of 94 °C for 45 s, 65 °C for 45 s, and 72 °C for 1.5 min and another 25 cycles of 94 °C for 45 s, 55 °C for 45 s, and 72 °C for 1.5 min, ending with a final extension step at 72 °C for 10 min and followed by a hold at 4 °C.
Agr specificity
The agr specificity groups were identified by PCR amplification of the hypervariable domain of the agr locus using primers specific for each of the four major specificity groups (agr I-IV) as proposed by Shopsin et al. [55] . Briefly, agr specificity groups were characterized using 5 µM pan-agr-F (5′-ATGCACATGGTGCACATGC-3′) as the forward primer and, four reverse primers (each 1.25 µM): agr-I-R (5′-GTCA CAAG TACT ATAA GCTGCGAT-3′); agr-II-R, (5′-GTAT TACT AATT GAAA AGTG CCATAGC-3′); agr-III-R, (5′-CTGT TGAA AAAG TCAA CTAA AAGCTC-3′); and agr-IV-R, (5′-CGATAATGCCGTAATAC CCG-3′). PCR conditions were the same as previously determined with an initial denaturation at 94 °C for 10 min, and 25 cycles of 94 °C for 1 min, 55 °C for 1 min, 72 °C for 1 min, ending with a final extension step at 72 °C for 10 min and followed by a hold at 4 °C.
All PCR primers were obtained from Invitrogen (Life Technology, Grand Island, NY, USA). All PCR assays were conducted using GoTaq Hot Start Green Master Mix consisting of GoTaq DNA Polymerase with 5X Green GoTaq Reaction Buffer (Promega Corporation, Madison, WI, USA). All PCR assays were conducted in 50 µl of PCR mixture and incorporated a reagent control (without template DNA).
gel analysis
The PCR products were visualized using a UV light box after electrophoresis on a 2% agarose gel. Gels were stained by 0.5 µg ml −1 ethidium bromide (Bio-Rad Laboratories, Hercules, CA, USA). The lengths of the PCR products were estimated by comparison with the 1-log (N0467S) or 2-log (N0469S) DNA ladder molecular size markers (New England BioLabs, Ipswich, MA, USA). Gels were recorded using a Scion Color Digital Camera (model CFW-1308c) and ScionVisicapture 2.0 (Scion Corporation, Frederick, MD, USA). Bands' presence/absence was analysed using Totallab TL 100 (Nonlinear Dynamics Ltd., Durham, NC, USA).
Computational analysis
Similarity matrices from binary banding data of the different primer combinations were derived with the Similarity for Qualitative Data Program (SIMQUAL) in the Numerical Taxonomy and Multivariate Analysis System for personal computer (NTSYS-pc) version 2.2. Estimates for similarity were based on Jaccard's coefficient. Matrices of similarity were analysed using the UPGMA (unweighted pair group method with arithmetic averages) clustering method. Clustering was done by sequential agglomerative hierarchical non-overlapping (SAHN) clustering using NTSYS-pc [56] . Dendrogram was generated with the tree option of NTSYSpc. Data were analysed with SPSS and Graph Pad Prism 4 software. Categorical data were analysed with Fisher's exact test. Continuous variables were compared using the MannWhitney U test for two groups, and with the Kruskall-Wallis for >two groups. Relationships between strains were further analysed and graphed using NTSYS-PC 2.2 (Exeter Software). Multiple analysis of variance (MANOVA) was used to determine the main and interaction effects of categorical variables on multiple dependent interval variables. P-values <0.05 are considered significant. Profiles with an insufficient number of isolates were not included in the subsequent statistical analysis.
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